The MedPAC Blog

  • Why have Medicare costs grown so much slower than the costs of employer-sponsored insurance?

    by MedPAC Staff | Sep 11, 2017
    In Medicare, the prices paid to providers are set by law. In contrast, commercial insurers usually negotiate prices with providers. As we discuss below, prices negotiated by commercial insurers vary wildly across providers and insurers, and prices have grown faster for providers with more market power.
    Full post
  • Factors increasing Part D spending for catastrophic benefits

    by MedPAC Staff | Jun 08, 2017
    From 2010 to 2017, Medicare spending on the monthly prospective payments grew rather slowly, and average premiums for Medicare Part D enrollees remained between $30 and $31 per month. However, Medicare spending on reinsurance payments for enrollees with high drug costs grew on average more than 20% per year since 2010. In this blog post, we discuss several factors that have contributed to that high growth in recent years.
    Full post
  • Trends in Medigap Enrollment, 2010 to 2015

    by MedPAC Staff | Feb 13, 2017
    The number of beneficiaries with Medigap policies has been growing, both in absolute terms, and as a share of beneficiaries in fee-for-service (FFS) Medicare. At the same time, a greater share of those with Medigap have chosen Medigap policies that include some significant amount of beneficiary liability for cost sharing. This blog post examines these trends using annual Medigap policy sales data from the National Association of Insurance Commissioners (NAIC) covering the years 2010 to 2015.
    Full post
  • Meeting highlight: hospital consolidation and its implications for Medicare

    by MedPAC Staff | Nov 15, 2016
    At its November public meeting, the Commission held a session to discuss hospital consolidation and its implications for the Medicare program. The Commission has been tracking trends in provider consolidation, Medicare and private insurer payment rates, and provider costs for many years. In this post, we pull together a variety of analyses from MedPAC and others for a comprehensive backgrounder on hospital consolidation and Medicare.
    Full post
  • Data book highlight: Rates of low-value service use and spending in Medicare

    by MedPAC Staff | Aug 23, 2016
    On Friday, MedPAC released its July 2016 data book. The data book is an annual MedPAC publication filled with charts and tables presenting much of the information from our March report, plus more, in a convenient and accessible reference guide. In this post, we’re highlighting two charts (5-7 and 5-8) about low-value care that can be found in this year’s edition.
    Full post
  • MedPAC releases drug briefings

    by MedPAC Staff | Jun 16, 2016
    When the Commission began its deliberations on drug policy, which ultimately shaped the contents of the June report, it started with two informational presentations that were intended to provide background and context for its discussions. The Commission is now releasing annotated versions of these presentations to serve as a resource for policymakers.
    Full post
  • Case mix, coding, and profitability in IRFs

    by MedPAC Staff | May 17, 2016
    The high margin for IRFs in 2014 indicates that, in aggregate, Medicare payments substantially exceed the costs of caring for beneficiaries. But margins differ considerably across IRFs. Since 2009, the aggregate margin for hospital-based IRFs—which account for 52 percent of IRF discharges—has been at or below 1 percent, while the aggregate margin for freestanding IRFs has been 20 percent or more. Further, since 2006, the disparity between hospital-based and freestanding IRFs’ margins has been widening. The growing disparity is likely due in part to differences in cost growth.
    Full post
  • March 2016 report highlight: HRAs and risk adjustment

    by MedPAC Staff | Apr 26, 2016
    MedPAC’s March 2016 report contains two recommendations for the Medicare Advantage (MA) program. This post will focus on the MA recommendation pertaining to health risk assessments (HRAs).
    Full post
  • Including hospice benefit in the MA benefit package

    by MedPAC Staff | Feb 19, 2016
    The Medicare hospice benefit is not included in the Medicare Advantage (MA) benefits package. MA enrollees who elect hospice remain in their MA plans, but fee-for-service (FFS) Medicare pays for their hospice services. This carve-out of hospice from MA fragments care accountability and financial responsibility for MA enrollees who elect hospice.
    Full post
  • Price growth of brand-name drugs and Part D

    by MedPAC Staff | Jan 27, 2016
    Evidence suggests that price growth for brand-name drugs is beginning to drive growth in average prices of all drugs covered under Part D.
    Full post

Next Public Meeting


For the latest news and press releases from MedPAC

Click Here

Join Our Mailing List

Sign up to recieve e-mail notices of Commission meetings and new posts to our website.

Sign Up Now

Filter posts by subject